Get the latest Nayzilam shortage update for 2026. Learn what's causing supply issues and what patients can do to find this seizure rescue medication.
If you rely on Nayzilam (Midazolam nasal spray) as a rescue medication for seizure clusters, staying informed about its availability is essential. In this article, we'll cover the current state of the Nayzilam supply, what's causing the shortage, and what you can do to protect yourself.
As of early 2026, Nayzilam continues to experience intermittent supply disruptions. Because it is manufactured by a single company — UCB Pharma — and has no generic equivalent, any interruption in production can quickly lead to shortages at pharmacies nationwide. Some patients report finding Nayzilam at specialty pharmacies while their local retail pharmacies remain out of stock.
For real-time availability, use MedFinder to check which pharmacies near you currently have Nayzilam in stock. You can also read our detailed guide: How to check if a pharmacy has Nayzilam in stock.
Several factors contribute to Nayzilam's availability challenges:
For more background, read our article: Why is Nayzilam so hard to find?
Request prescription refills well before your current supply runs out. Give yourself at least two to three weeks of lead time to account for any ordering delays or insurance processing.
Visit MedFinder to search for pharmacies with Nayzilam in stock. This is faster and more reliable than calling individual pharmacies. For a full walkthrough, see how to find Nayzilam in stock near you.
Ask your neurologist to prescribe a backup rescue medication, such as Valtoco (Diazepam nasal spray) or Diastat. Having an alternative on hand ensures you're never completely without seizure rescue coverage.
UCB Pharma offers patient support through UCBCares. They may be able to help you locate a pharmacy with stock or provide information about expected supply timelines.
The FDA Drug Shortage Database and the ASHP Drug Shortage Resource Center both track medication shortages. While updates may lag behind real-world availability, they provide official information about the scope and expected duration of shortages.
If your pharmacy can't fill your Nayzilam prescription due to a shortage, contact your insurance company. Many insurers will:
Document everything — keep records of pharmacy calls confirming the shortage, as this can help when appealing insurance decisions.
The long-term solution to Nayzilam availability issues would be the introduction of a generic version of Midazolam nasal spray or the approval of additional manufacturers. As of 2026, no generic Nayzilam has been approved, but this could change in the coming years as patent protections evolve.
In the meantime, staying proactive is your best defense. Keep your prescriptions current, maintain a backup rescue medication, and use tools like MedFinder to stay ahead of supply issues.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
